Skip to the page

Data / Drug companies / Sterling Chemical Malta Ltd

Sterling Chemical Malta Ltd: 20 products in the FDA NDC directory, labeler code 59057

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Sterling Chemical Malta Ltd (labeler code 59057) lists 20 products in the FDA National Drug Code Directory. By type: 20 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on September 2, 2024.

The request: Watch Sterling Chemical Malta Ltd (FDA labeler code 59057): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
59057
Products in commercial distribution
20
Packages
20
Finished drugs by generic name
0
Prescription products
0
Over the counter products
0
Started marketing in the last 12 months
0
Earliest marketing start
February 5, 2013
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Bulk ingredients1785%
Bulk ingredients for compounding315%

Products by type

TypeProductsShare
Bulk ingredients20100%

Dosage forms

Dosage formProductsShare
Powder20100%

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Cabozantinib59057-019PowderBulk ingredientsSeptember 2, 2024
Cabozantinib59057-018PowderBulk ingredientsSeptember 2, 2024
Vilanterol trifenatate59057-017PowderBulk ingredientsMay 26, 2023
Vilanterol trifenatate59057-016PowderBulk ingredientsMay 26, 2023
Drospirenone59057-015PowderBulk ingredientsMay 12, 2023
Drospirenone59057-014PowderBulk ingredientsMay 12, 2023
Cabozantinib s-malate59057-013PowderBulk ingredientsAugust 31, 2022
Umeclidinium bromide59057-012PowderBulk ingredientsJune 15, 2022
Umeclidinium bromide59057-011PowderBulk ingredientsJune 15, 2022
Fluticasone furoate59057-010PowderBulk ingredientsJanuary 4, 2022
Fluticasone furoate59057-009PowderBulk ingredientsJanuary 4, 2022
Exemestane59057-008PowderBulk ingredients for compoundingFebruary 27, 2018
Exemestane59057-007PowderBulk ingredients for compoundingFebruary 27, 2018
Abiraterone acetate59057-006PowderBulk ingredients for compoundingNovember 11, 2015
Dutasteride59057-005PowderBulk ingredientsApril 10, 2015
Dutasteride59057-004PowderBulk ingredientsMarch 31, 2015
Levonorgestrel59057-002PowderBulk ingredientsJanuary 9, 2014
Levonorgestrel59057-001PowderBulk ingredientsJanuary 8, 2014
Abiraterone acetate59057-000PowderBulk ingredientsAugust 7, 2013
Fulvestrant59057-003PowderBulk ingredientsFebruary 5, 2013

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.